ClinicalTrials.Veeva

Menu

COMPARATIVE EFFECTS OF PERIOPERATIVE AND ADJUVANT CHEMOTHERAPY ON OUTCOMES OF OPERABLE GASTRIC CANCER: EXPERIENCE FROM A CANCER CARE CENTER

S

Shaukat Khanum Memorial Cancer Hospital & Research Centre

Status

Completed

Conditions

Gastric Cancer, Outcomes, Pakistan, Adjuvant Chemotherapy, Perioperative Chemotherapy

Study type

Observational

Funder types

Other

Identifiers

NCT04989764
EX-05-03-20-40

Details and patient eligibility

About

  • Patients with gastric adenocarcinoma
  • Comparison: perioperative chemotherapy vs. adjuvant therapy.
  • Sample size differences between the two groups.
  • Kaplan meier survival analysis, overall survival and disease free survival

Enrollment

108 patients

Sex

Volunteers

No Healthy Volunteers

Inclusion criteria

  • We included histologically proven gastric adenocarcinoma patient with operable disease and the patients who completed their prescribed perioperative or adjuvant chemotherapy cycles

Exclusion criteria

  • Patients were excluded if they had Tis or T1, N0 disease, inoperable disease, metastatic. In addition, all those who did not undergo adequate lymphadenectomy (< D2) or had R1 margins following surgery were excluded

Trial design

108 participants in 2 patient groups

perioperative chemotherapy vs. adjuvant therapy in gastric ca patients
perioperative chemotherapy group vs. adjuvant chemotherapy group

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems